Cassava Sciences (NASDAQ:SAVA - Get Free Report) issued its earnings results on Monday. The company reported ($0.57) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.68) by $0.11, Zacks reports.
Cassava Sciences Stock Up 2.2 %
Shares of NASDAQ SAVA traded up $0.06 during mid-day trading on Thursday, reaching $2.82. 1,572,296 shares of the company were exchanged, compared to its average volume of 2,844,869. Cassava Sciences has a twelve month low of $2.23 and a twelve month high of $42.20. The company's 50-day simple moving average is $2.55 and its 200-day simple moving average is $15.03. The stock has a market capitalization of $135.67 million, a P/E ratio of -2.04 and a beta of -1.24.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reiterated a "neutral" rating on shares of Cassava Sciences in a research note on Tuesday.
Check Out Our Latest Analysis on SAVA
About Cassava Sciences
(
Get Free Report)
Cassava Sciences, Inc, a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease.
Recommended Stories
Before you consider Cassava Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cassava Sciences wasn't on the list.
While Cassava Sciences currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
